Literature DB >> 9254089

Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment.

G D Anderson1, Y X Lin, C Berge, G A Ojemann.   

Abstract

Valproate (VPA) is associated with a variety of idiosyncratic hematological effects including thrombocytopenia, inhibition of platelet aggregation, and fibrinogen depletion. This has led some investigators to recommend discontinuation of VPA therapy prior to elective surgical procedures. However, administration of VPA therapy is not altered prior to surgery at the authors' center and no VPA-associated bleeding complications have been observed. Therefore, a retrospective chart review was conducted to verify the clinical observations in patients who had undergone cortical resection while receiving antiepileptic drugs (AEDs). Baseline, surgical, and postoperative laboratory data were available for a total of 313 patients, 111 of whom were receiving VPA and 202 of whom were receiving AEDs without VPA (control patients). Eighty-seven percent of the patients receiving VPA were also being treated with at least one other AED. The control group was approximately equally divided between monotherapy (55%) and polytherapy (45%) treatments. Platelet counts were significantly lower in the control polytherapy (284 +/- 74 x 10(9)/L) and both VPA groups (279 +/- 113 x 10(9)/L) as compared with the control monotherapy group (314 +/- 85 x 10(9)/L). Baseline fibrinogen levels were significantly lower in the VPA than in the control groups (223 +/- 91 g/dl vs. 278 +/- 95 g/dl). Both pre- and postoperatively, the VPA group had lower red blood cells counts, hematocrit, and hemoglobin levels. There was no significant difference between groups in estimated blood loss during surgery or qualitative wound discharge postsurgery. There was only one case of a bleeding complication, which occurred 14 days postoperatively in a patient receiving carbamazepine monotherapy. The results of this study confirm the clinical observations of an absence of bleeding complications in patients receiving VPA therapy at the time of surgery, despite differences in laboratory parameters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254089     DOI: 10.3171/jns.1997.87.2.0252

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  [Status epilepticus].

Authors:  B Feddersen; E Trinka
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

2.  Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

Authors:  M Weller; T Gorlia; J G Cairncross; M J van den Bent; W Mason; K Belanger; A A Brandes; U Bogdahn; D R Macdonald; P Forsyth; A O Rossetti; D Lacombe; R-O Mirimanoff; C J Vecht; R Stupp
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

Review 3.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

Review 4.  Valproic acid in epilepsy : pregnancy-related issues.

Authors:  Pierre Genton; Franck Semah; Eugen Trinka
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Valproate as a mainstay of therapy for pediatric epilepsy.

Authors:  Renzo Guerrini
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 6.  The preoperative neurological evaluation.

Authors:  John Probasco; Bogachan Sahin; Tung Tran; Tae Hwan Chung; Liana Shapiro Rosenthal; Zoltan Mari; Michael Levy
Journal:  Neurohospitalist       Date:  2013-10

Review 7.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 8.  Epilepsy and brain tumors.

Authors:  Dario J Englot; Edward F Chang; Charles J Vecht
Journal:  Handb Clin Neurol       Date:  2016

9.  Complications to invasive epilepsy surgery workup with subdural and depth electrodes: a prospective population-based observational study.

Authors:  Emelie Hedegärd; Johan Bjellvi; Anna Edelvik; Bertil Rydenhag; Roland Flink; Kristina Malmgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-29       Impact factor: 10.154

10.  Analytical Method Development for Sodium Valproate through Chemical Derivatization.

Authors:  Murad Abualhasan; Nihaya Wasif Odeh; Ghadeer Naser Younis; Oyoun Fadel Zeidan
Journal:  Int J Anal Chem       Date:  2020-01-31       Impact factor: 1.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.